US approves first new Alzheimer’s drug in almost 2 decades

WASHINGTON: The US on Monday approved a drug called Aduhelm to treat patients with Alzheimer’s, the first new medicine against the disease in almost two decades and the first to address cognitive decline linked to the condition.

The decision was highly anticipated but also contentious, because an independent expert panel convened by the regulatory Food and Drug Administration last November found insufficient evidence of Aduhelm’s benefit and recommended against approval.

To continue reading please click here

Leave a Reply

Back to top button